Who are Thermo Fisher Scientific's decision-makers?
Thermo Fisher Scientific is led by Marc N. Casper. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, compliance, finance, and operational stakeholders.
- CEO
- Marc N. Casper
- CFO/key exec
- Jim Meyer
- Founded
- 2006
- Employees
- 125,000+
- HQ
- Waltham, MA
- Status
- NYSE: TMO
- Marc N. CasperChairman and Chief Executive OfficerCEO since 2009; Chairman since 2020Long-tenured leader of Thermo Fisher's post-merger scale-up and M&A strategy.
- Jim MeyerSenior Vice President and Chief Financial OfficerCFO effective March 2026Finance leader who succeeded Stephen Williamson after an announced transition.
- Andy ThomsonPresident and Chief Operating OfficerPresident/COO leadership teamOversees major operating execution across the global platform.
- Josh FarleySenior Vice President and Chief Information OfficerSenior executive leadershipKey technology and digital operations stakeholder for enterprise systems.
Who leads Thermo Fisher Scientific?
Thermo Fisher Scientific's leadership team combines enterprise healthcare operations, finance, clinical, product, technology, legal, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at Thermo Fisher Scientific?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, data-security, compliance, privacy, and implementation owners. Clinical, reimbursement, or quality stakeholders become essential whenever the purchase touches patient care, regulated data, medical products, or payer/provider economics.
How is Thermo Fisher Scientific organized as it scales?
Thermo Fisher Scientific operates through business units tied to Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. That creates multiple entry points, but enterprise standards for security, compliance, contracting, and vendor management can still control the final approval path.
As of June 2026.Sources:Thermo Fisher Scientific leadershipThermo Fisher Scientific annual reports
Thermo Fisher Scientific — frequently asked questions
